CEO Joe Almeida said M&A deals, particularly smaller tuck-in acquisitions, will continue to play a key role in Baxter's growth strategy.
News & Features
Recovery technology mogul Game Ready received FDA 510(k) clearance for its rehabilitation therapy that provides orthopedic treatment options for patients around the world.
With a spate of hurricanes, wildfires, and earthquakes front of mind, here's what medtech companies can do to fortify against future natural disasters.
These are the three questions vendors need to answer during research and development for their clinical wearable to be adopted enthusiastically by hospitals, patients, and doctors.
A recent scientific statement by the American Heart Association shines a spotlight on cardiovascular genomic testing and gives a nod to two such technologies that are currently on the market.
Mechanical and chemical testing are needed to bring complex drug-delivery products and other combination products to market.
Health IT security firm Imprivata has acquired a segment of Caradigm from GE Healthcare. The deal comes just days after GE announced plans to sell off $20 billion worth of assets over the next one to two years.
Medical device companies willing to align their research activities with government objectives can enjoy increased product development opportunities and financial returns.
Sonic experiences matter in medical products. By aligning the process of product sound design with medical guidelines for alerts and alarms, medical devices gain a new opportunity to connect more deeply with their users.
Best-selling author, cardiologist, and digital health researcher Eric Topol hopes artificial intelligence can help bring empathy back to healthcare.
New surgical robotics systems entering the U.S. market may cause a ripple in Intuitive Surgical's sales cycle, but CEO Gary Guthart says the company's experience will ultimately prevail over the incoming competition.
Digital health is gaining steam, but the successes have been limited to small patient groups and studies. Can digital health products get to the next level and impact wide swaths of the population?
In a new warning letter to Magellan Diagnostics, FDA accused the company of several legal violations, including marketing significantly modified versions of two of its blood lead testing systems without regulatory clearance and failing to submit medical device reports after learning of faulty blood test results.